10/26 FDA Meeting: Pfizer is Asked if Risks Outweigh Benefits

fizer was asked about a scenario in their briefing document which showed hospitalizations from vaccine-induced Myocarditis exceeding those from COVID-19. Pfizer acknowledged this being possible but highlighted that getting children back to school may help outweigh this risk.